Dr. Jorge Arrubla
Scientific Study Advisor
medical doctor
Profil answer for diabetes
Germany
Biography
Jorge finished medical school in 2010 and defended his M.D. thesis at the RWTH Aachen University. He is PhD in biomedical and pharmaceutical sciences from the University of Liège and University of Maastricht (joint degree). He has a strong background in imaging techniques and has published a number of papers in that field. He got both scientific and clinical experience before joining Profil in 2015, where he started a career in clinical research with a special interest in medications for type 2 diabetes. He is currently participating in the specialisation program in clinical pharmacology directed by Dr. Grit Andersen.
Research Interest
Bolusing frequency and amount impacts gluThe effect of empagliflozin on muscle sympathetic nerve activity in patients with type 2 diabetes mellitus.cose control during hybrid closed-loop.